Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2009 · first_quarter · 1T
HR 1548 Pathway for Biosimilars Act -- focus on orphan drug issues HR 1427 Promoting Innovation and Access to Life Saving Medicine Act -- focus on orphan drug issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2009 · first_quarter · 1T
Source: Senate LDA
Stem Cell Research Improvement Act of 2009
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009
Stem Cell Research Enhancement Act of 2009
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009
Stem Cell Research Enhancement Act of 2009
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Newborn Screening Saves Lives Act of 2008
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Newborn Screening Saves Lives Act of 2008
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
HR 5629 Pathway for Biosimilars Act
HR 5629 Pathway for Biosimilars Act
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
Stem Cell Research Enhancement Act of 2008
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
The Stem Cell Research Enhancement Act, HR 7141
Stem Cell Research Enhancement Act of 2008
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2008 HR 7141
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Newborn Screening Saves Lives Act of 2007
Client: SHIRE PHARMACEUTICALS · Firm: THE WERNER GROUP
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Access to Life-Saving Medicine Act
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Newborn Screening Saves Lives Act of 2007
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Food and Drug Administration Amendments Act of 2007
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Medicare Cost Contract Extension and Refinement Act of 2007
Client: UCARE MINNESOTA · Firm: THE WERNER GROUP
S. 130 Medicare Cost Contract Extension and Refinement Act of 2007 H.R. 3162, the Children's Health and Medicare Protection Act of 2007
Medicare Cost Contract Extension and Refinement Act of 2007
Client: UCARE MINNESOTA · Firm: THE WERNER GROUP
S. 130 Medicare Cost Contract Extension and Refinement Act of 2007 H.R. 3162 The Children's Health and Medicare Protection Act of 2007
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Newborn Screening Saves Lives Act of 2007
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Stem Cell Research Enhancement Act of 2007
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Access to Life-Saving Medicine Act
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Newborn Screening Saves Lives Act of 2007
Client: SHIRE HUMAN GENETIC THERAPIES · Firm: THE WERNER GROUP
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Medicare Cost Contract Extension and Refinement Act of 2005
Client: UCARE MINNESOTA · Firm: THE WERNER GROUP
S 1403, HR 4050 Medicare Cost Contract Extension and Refinement Act of 2005 HR 6111 The Tax Relief and Health Care Act of 2006
Stem Cell Research Enhancement Act of 2005
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: THE WERNER GROUP
HR 810, S 471; The Stem Cell Research Enhancement Act HR 6143 The Ryan White HIV/AIDS Treatment Modernization Act of 2006
HR 873, S 487 The Stem Cell Research Enhacement Act of 2009 HR 872, The Stem Cell Research Improvement Act of 2009
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2008 · fourth_quarter · Q4
HR 5629 Pathway for Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2008 · fourth_quarter · Q4
The Stem Cell Research Enhancement Act, HR 7141
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2008 · third_quarter · Q3
HR 5629 Pathway for Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2008 · third_quarter · Q3
Stem Cell Research Enhancement Act of 2008 HR 7141
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2008 · second_quarter · Q2
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
Filing targets: HOUSE OF REPRESENTATIVES
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2008 · second_quarter · Q2
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2008 · first_quarter · Q1
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2008 · first_quarter · Q1
HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007 HR 5629 Pathway for Biosimilars Act
SHIRE PHARMACEUTICALS via THE WERNER GROUP
2008 · first_quarter · RR
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
HR 5629 The Pathway for Biosimilars Act HR 3825 The Newborn Screening Saves Lives Act Reimbursement for home infusion services under Medicare
SHIRE HUMAN GENETIC THERAPIES via THE WERNER GROUP
2007 · year_end · YT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2007 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY HEALTH CHARITIES via THE WERNER GROUP
2007 · year_end · YT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCARE MINNESOTA via THE WERNER GROUP
2007 · year_end · YT
S. 130 Medicare Cost Contract Extension and Refinement Act of 2007 H.R. 3162 The Children's Health and Medicare Protection Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE HUMAN GENETIC THERAPIES via THE WERNER GROUP
2007 · mid_year · MM
S. 1082, HR 2900 Food and Drug Administration Amendments Act of 2007 S. 623, HR 1038 Access to Life-Saving Medicine Act HR 2889, S. 1712 SHINE Act HR 1634, S. 634, S. 1858 Newborn Screening Saves Lives Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCARE MINNESOTA via THE WERNER GROUP
2007 · mid_year · MM
S. 130 Medicare Cost Contract Extension and Refinement Act of 2007 H.R. 3162, the Children's Health and Medicare Protection Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY HEALTH CHARITIES via THE WERNER GROUP
2007 · mid_year · MM
OPM regulation, "Solicitation of Federal Civilian and Uniformed Service Personnel for Contributions to Private voluntary Organizations -- Charity Recoding", published in Federal Register, 12/21/06
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2007 · mid_year · MM
Stem Cell Research Enhancement Act of 2007 (S.5 and HR 3)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SHIRE HUMAN GENETIC THERAPIES via THE WERNER GROUP
2007 · year_end · RR
Follow-on biologics/biosimilars Newborn screening Drug safety Orphan drug incentives
COMMUNITY HEALTH CHARITIES via THE WERNER GROUP
2006 · year_end · YY
Proposed changes to the Combined Federal Campaign, 5 CFR part 950. Federal Register notice June 29, 2006
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCARE MINNESOTA via THE WERNER GROUP
2006 · year_end · YY
S 1403, HR 4050 Medicare Cost Contract Extension and Refinement Act of 2005 HR 6111 The Tax Relief and Health Care Act of 2006
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2006 · year_end · YY
HR 810, S 471; The Stem Cell Research Enhancement Act HR 6143 The Ryan White HIV/AIDS Treatment Modernization Act of 2006
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY HEALTH CHARITIES via THE WERNER GROUP
2006 · mid_year · RR
Administrative and programmatic changes to the Combined Federal Campaign; "Solicitation of Federal Civilian and Uniformed Service Personnel for Contributions to Private Voluntary Organizations -- Eligibility and Public Accountability Standards"
UCARE MINNESOTA via THE WERNER GROUP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UCARE MINNESOTA via THE WERNER GROUP
2005 · mid_year · RR
UCARE MINNESOTA via THE WERNER GROUP
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via THE WERNER GROUP
2005 · year_end · RR